Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

Share Price is delayed by 15 minutes
Get Live Data
331.50    0.00 (0.00%)
Bid:
330.00
Ask:
333.00
Spread: 3.00 (0.909%)
Market Cap: £228.89m
ANCR Live PriceLast checked at - London Stock Exchange

Intraday Animalcare Grp Share Chart

AGM Statement

18 Nov 2014 07:00

RNS Number : 2569X
Animalcare Group PLC
18 November 2014
 



 

 

 

Animalcare Group plc

("Animalcare")

 

AGM Statement

 

Animalcare (AIM: ANCR), a leading supplier of veterinary medicines, will hold its Annual General Meeting at its head office, 10 Great North Way, York Business Park, York YO26 6RB at 11.30am today.

 

Ahead of the formal proceedings, Chairman James Lambert will provide the following update to shareholders:

 

"The Board is pleased to announce that trading in the first four months of the financial year is ahead of prior year and in line with management expectations.

 

Our investment in the infrastructure of the business is starting to deliver returns, including positive results from key account management and our new telesales team. Our product development pipeline is progressing well against internal project management milestones.

 

We announced on 15th October 2014, that the Board has proposed the payment of an increased final dividend of 4.0 pence per share, giving a total dividend for the year of 5.5 pence per share, representing a 3.8% increase on the prior year. Formal approval will be sought at the AGM today.

 

Together with my fellow Board members, we would like to take this opportunity to thank our valued shareholders and stakeholders. The management of Animalcare has worked hard to build a solid foundation for the business, on which to deliver a step change in product development and sustained growth in the years to come. As a Board we remain confident that we are on track to deliver results for the full year in line with market expectations."

 

 

For further information, please contact:

 

Animalcare Group plc

Tel: 01904 487 687

Iain Menneer, Chief Executive Officer

 

Chris Brewster, Chief Financial Officer

 

 

 

 

Panmure Gordon (Nominated Adviser and Broker)

 

Joanne Lake/Peter Steel

Tel: 0113 357 1150

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or animalcare@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

Notes to editors

 

Animalcare is a leading veterinary sales and marketing company based in York with 57 employees including a field sales force of 16 selling to all veterinary practices around the United Kingdom.

 

Animalcare has developed a range of generic veterinary medicines and animal identification products primarily to companion animal veterinary markets.  

 

Animalcare operates in three product areas:

 

· Licensed Veterinary Medicines - a range of branded veterinary licensed pharmaceuticals sold to veterinary professionals in the UK and selected markets in Northern Europe. The range can be divided into four main categories; antibacterials, anaesthetics and analgesics, Aqupharm intravenous fluids and vitamins & speciality pharmaceuticals.

 

· Companion Animal Identification - Identichip is the pioneering microchip identification system in the UK. Animalcare also owns and operates the Anibase database; together the market leader in electronic identification for pets in the UK.

 

· Animal Welfare Products - a range used by veterinary professionals in the diagnosis and care of their patients, for example intravenous infusion accessories, ophthalmic instruments, hygiene solutions and bandages and dressings.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFFMFWWFLSESF
Date   Source Headline
30th Sep 20257:00 amRNSInterim Results for six months ended 30 June 2025
24th Sep 20257:00 amRNSCollaboration to develop treatment for sweet itch
23rd Sep 20257:00 amRNSNotice of Results & Presentations
22nd Aug 20257:00 amRNS-RAcquisition of VHH NGF programme & related assets
24th Jul 20257:00 amRNSH1 Trading Update and Notice of Results
13th Jun 20257:42 amRNSStrategic investment in Australian business
10th Jun 20254:36 pmRNSResult of 2025 AGM
30th May 20257:00 amRNSExercise of Options and Total Voting Rights
23rd May 20259:21 amRNSNotification of Major Holding in Company
16th May 20257:00 amRNS2024 Annual Report and Notice of 2025 AGM
29th Apr 20252:06 pmRNSFinal Dividend Timetable
29th Apr 20257:00 amRNSPreliminary Full Year Results
22nd Apr 20251:23 pmRNSNotification of Major Holding in Company
16th Apr 20257:00 amRNSNotice of Results and Presentations
23rd Jan 20257:00 amRNS2024 Full Year Trading Update
20th Jan 20257:00 amRNSExercise of Options and Total Voting Rights
3rd Jan 202510:12 amRNSCompletion of Randlab acquisition
2nd Jan 202510:11 amRNSNotification of Total Voting Rights
10th Dec 20247:00 amRNSAppointment of Alternate Director
6th Dec 20243:44 pmRNSNotification of Major Holding in the Group
6th Dec 20243:11 pmRNSNotification of Major Holding in the Group
6th Dec 20241:31 pmRNSPDMR Dealing
6th Dec 20241:07 pmRNSNotification of Major Holding in the Group
5th Dec 20246:04 pmRNSNotification of Major Holding in the Company
5th Dec 20244:35 pmRNSNotification of Major Holding in the Group
5th Dec 20241:26 pmRNSNotification of Major Holding in Company
5th Dec 20249:13 amRNSEquity Raise Post-Transaction Report
3rd Dec 202412:46 pmRNSResults of the Fundraise
3rd Dec 20247:16 amRNSConditional acquisition of Randlab
3rd Dec 20247:09 amRNSProposed fundraise to raise c£20m + Board update
10th Oct 20247:00 amRNSNotification of Major Holding in Company
9th Oct 20248:00 amRNSInvestor Presentation via Investor Meet Company
24th Sep 20247:00 amRNSInterim Results for six months ended 30 June 2024
24th Jul 20247:00 amRNSH1 Trading Update and Notice of Interim Results
20th Jun 20244:57 pmRNSResult of 2024 AGM and Board Changes
31st May 20247:00 amRNSTotal Voting Rights - 31 May 2024
22nd May 20245:41 pmRNSNotification of Major Holding in Company
21st May 20244:49 pmRNS2023 Annual Report and Notice of 2024 AGM
21st May 20243:50 pmRNSNotification of Holding in Company
16th May 20247:00 amRNSPDMR dealing, Admission and Total Voting Rights
15th May 20247:00 amRNSExercise of Options and Total Voting Rights
25th Apr 20247:00 amRNSGrant of options and PDMR Dealing
11th Apr 20242:57 pmRNSSale of equity in STEM Animal Health Inc.
9th Apr 20248:22 amRNSInvestor presentation via Investor Meet Company
9th Apr 20247:00 amRNSPreliminary Unaudited Full Year Results 2023
28th Feb 20247:00 amRNSDisposal of Identicare Ltd
29th Jan 202410:27 amRNSNotification of Major Holding
25th Jan 20247:00 amRNSTrading Update and Notice of 2023 FY Results
9th Nov 20232:01 pmRNSNotification of Major Holding
1st Nov 202311:38 amRNSNotification of Major Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.